PDIA3 Inhibits Mitochondrial Respiratory Function in Brain Endothelial Cells and C. Elegans Through STAT3 Signaling and Decreases Survival After OGD
Overview
Cell Biology
Affiliations
Background: Protein disulfide isomerase A3 (PDIA3, also named GRP58, ER-60, ERp57) is conserved across species and mediates protein folding in the endoplasmic reticulum. PDIA3 is, reportedly, a chaperone for STAT3. However, the role of PDIA3 in regulating mitochondrial bioenergetics and STAT3 phosphorylation at serine 727 (S727) has not been described.
Methods: Mitochondrial respiration was compared in immortalized human cerebral microvascular cells (CMEC) wild type or null for PDIA3 and in whole organism C. Elegans WT or null for pdi-3 (worm homologue). Mitochondrial morphology and cell signaling pathways in PDIA3-/- and WT cells were assessed. PDIA3-/- cells were subjected to oxygen-glucose deprivation (OGD) to determine the effects of PDIA3 on cell survival after injury.
Results: We show that PDIA3 gene deletion using CRISPR-Cas9 in cultured CMECs leads to an increase in mitochondrial bioenergetic function. In C. elegans, gene deletion or RNAi knockdown of pdi-3 also increased respiratory rates, confirming a conserved role for this gene in regulating mitochondrial bioenergetics. The PDIA3-/- bioenergetic phenotype was reversed by overexpression of WT PDIA3 in cultured PDIA3-/- CMECs. PDIA3-/- and siRNA knockdown caused an increase in phosphorylation of the S727 residue of STAT3, which is known to promote mitochondrial bioenergetic function. Increased respiration in PDIA3-/- CMECs was reversed by a STAT3 inhibitor. In PDIA3-/- CMECs, mitochondrial membrane potential and reactive oxygen species production, but not mitochondrial mass, was increased, suggesting an increased mitochondrial bioenergetic capacity. Finally, PDIA3-/- CMECs were more resistant to oxygen-glucose deprivation, while STAT3 inhibition reduced the protective effect.
Conclusions: We have discovered a novel role for PDIA3 in suppressing mitochondrial bioenergetic function by inhibiting STAT3 S727 phosphorylation.
Weng C, Xu J, Ying X, Sun S, Hu Y, Wang X Heliyon. 2024; 10(17):e36357.
PMID: 39286134 PMC: 11403428. DOI: 10.1016/j.heliyon.2024.e36357.
Effects of vitamin D signaling in cardiovascular disease: centrality of macrophage polarization.
Fliri A, Kajiji S Front Cardiovasc Med. 2024; 11:1388025.
PMID: 38984353 PMC: 11232491. DOI: 10.3389/fcvm.2024.1388025.
Fan J, Wang L, Zhang C, Wu X, Han L, Zhang X Aging (Albany NY). 2024; 16(10):8880-8897.
PMID: 38761176 PMC: 11164521. DOI: 10.18632/aging.205847.
Wisniewska K, Gaffke L, Zabinska M, Wegrzyn G, Pierzynowska K Curr Issues Mol Biol. 2024; 46(3):2678-2700.
PMID: 38534785 PMC: 10968730. DOI: 10.3390/cimb46030169.
Nowak J, Olszewska A, Wierzbicka J, Gebert M, Bartoszewski R, Zmijewski M Cells. 2024; 13(1).
PMID: 38201216 PMC: 10778127. DOI: 10.3390/cells13010011.